Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
163,926,065
-
Total 13F shares
-
110,971,178
-
Share change
-
+15,616,954
-
Total reported value
-
$3,915,828,772
-
Put/Call ratio
-
30%
-
Price per share
-
$35.29
-
Number of holders
-
192
-
Value change
-
+$557,144,607
-
Number of buys
-
122
-
Number of sells
-
65
Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q2 2024
As of 30 Jun 2024 Dyne Therapeutics, Inc. - COMMON STOCK (DYN) had 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 110,971,178 shares of stock of the company.
Largest 10 holders included Atlas Venture Life Science Advisors, LLC, FCPM III SERVICES B.V., BlackRock Inc., RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, and Deep Track Capital, LP.
This table shows 191 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.